Dme Capital Management, LP Viatris Inc Transaction History
Dme Capital Management, LP
- $2.04 Trillion
- Q2 2024
A detailed history of Dme Capital Management, LP transactions in Viatris Inc stock. As of the latest transaction made, Dme Capital Management, LP holds 7,399,810 shares of VTRS stock, worth $84.7 Million. This represents 3.85% of its overall portfolio holdings.
Number of Shares
7,399,810
Previous 4,517,620
63.8%
Holding current value
$84.7 Million
Previous $53.9 Billion
45.83%
% of portfolio
3.85%
Previous 2.47%
Shares
2 transactions
Others Institutions Holding VTRS
# of Institutions
1,086Shares Held
970MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.61 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.06 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$711 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$659 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$651 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.9B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...